Fig. 2From: Human pluripotent stem cell differentiation to functional pancreatic cells for diabetes therapies: Innovations, challenges and future directionsPancreatic differentiation [36] of hPSCs (H9 hESCs) modified from Kroon et al. [41]. The factors used for differentiation are shown in red font (CYC: KAAD-cyclopamine, IGF2: insulin-like growth factor 2). Islet-like clusters were infected with a recombinant adenovirus carrying a bicistronic cassette with the green fluorescent protein (GFP) under the cytomegalovirus (CMV) promoter and the DsRed reporter under the rat insulin promoter. Immunostainings for specific markers at each stage are shownBack to article page